Hepatitis C in US Prisons: Prevalence & Barriers to Screening and Treating


Anne C. Spaulding, MD, MPH

Associate Professor, Department of Epidemiology, Emory University Rollins School of Public Health

Learning Objectives:

1. To be able to describe the portion of the US Hepatitis C epidemic borne by persons who go in and out of jails and prisons over the course of a year.
2. To explain why elimination of Hepatitis C in the US depends on treating correctional populations.
3. To describe the challenges prisons face in financing Hepatitis C cure for persons who are incarcerated.

A live webcast sponsored by:

Merck (Grant No. AAN170209041806), The N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667) and Clinical Directors Network, Inc. (CDN)


Thursday, January 25, 2018 from 12:30 PM to 2:00 PM EST

This activity is approved for up to 1.5 Prescribed credit(s) by the American Academy of Family Physicians (AAFP). Enduring CME Credits valid until January 25, 2019.

Recent Webcasts

Innovative Strategies to Eliminate HCV

Dr. Andrew H. Talal, MD, MPH
Professor of Medicine and Director of the Center for Research and Clinical Care and Research in Liver Disease at the University of Buffalo
A live webcast sponsored...